Showing results (141-150 of 324) with videos related to

Sort By:
Pageof 33
Vaccine|February 10, 2009
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergyPrakash Thapa, Guodong Zhang, Chengfeng Xia, et al.
Melanoma Research|August 20, 2016
A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanomaJennifer L McQuade, Liberty P Posada, Srisuda Lecagoonporn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2020
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II StudyMeredith S Pelster, Stephen K Gruschkus, Roland Bassett, et al.
Journal of Cutaneous Pathology|July 20, 2012
BRAF, NRAS and KIT sequencing analysis of spindle cell melanomaJinhyun Kim, Alexander J Lazar, Michael A Davies, et al.
Journal for Immunotherapy of Cancer|June 20, 2024
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic visionLeisha A Emens, Pedro J Romero, Ana Carrizosa Anderson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2Richard W Joseph, Jeanette E Eckel-Passow, Ruchi Sharma, et al.
Melanoma Research|July 16, 2008
Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatmentCindy S Hwang, Victor G Prieto, Abdul H Diwan, et al.
Nature Immunology|August 30, 2011
The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunityMikyoung Chang, Wei Jin, Jae-Hoon Chang, et al.
Pageof 33